Summary
Anticholinergic agents have proved to be powerful bronchodilating drugs in various types of chronic obstructive pulmonary disease. Atropine given as an aerosol had a stronger bronchodilating effect, even in low doses not producing side-effects, than after peroral or intramuscular administration. Sch 1000, a new quater-nized atropine derivative had a stronger and more prolonged bronchodilator effect, even in significantly lower doses, and no side effects were observed. Because of its adventageous characteristics, Sch 1000 seems to be the anticholinergic agent to be preferred in clinical practice. It shows a wider therapeutic range than the beta adrenergic agent orciprenaline. A vagus-mediated reflex mechanism may be involved in histamine-induced bronchoconstriction. Experimental results show that a cholinergic mechanism and increased parasympathetic tone are important factors in the pathological mechanism of chronic airways obstruction.
Similar content being viewed by others
References
Bauer, R., Wick, H.: Ipratropium-bromid (Sch 1000) als Aerosol — ein Anticholinergikum zur Behandlung obstruktiver Atemwegserkrankungen. In: Tagungsberichte vom ersten Internationalen Kongress für Aerosole in der Medizin. 19. – 21. 9. 1973, S. 333 – 346, Baden/Wien
Bauer, R., Kulm, F.S., Stockhaus, K., Wick, H.: Exposé über Sch 1000, Magensekretionshemmer und Spasmolytikum. In: Biologische Forschung-Pharmakologie. Ingelheim/Rh.: C.H. Boehringer Sohn 1968
Cabezas, G.A., Graf, P.D., Nadel, J.A.: Sympathetic versus parasympathetic nervous regulation of airways in dogs. J. appl. Physiol.31, 651–665 (1971)
Chamberlain, D.A., Muir, D.C.F., Kennedy, K.P.: Atropine methonitrate and isoprenalin in bronchial asthma. Lancet1962 II, 1019–1021
Colebatch, H.J.H., Halmágyi, D.F.J.: Effect of vagotomy and vagal stimulation on lung mechanics and circulation. J. appl. Physiol.18, 881–887 (1963)
Du Bois, A.B., Dautrebande, L.: Acute effects of breathing inert dust particles and of carbachol aerosol on the mechanical characteristics of the lungs in man. Changes in response after inhaling sympathomimetic aerosols. J. clin. Invest.37, 1746–1755 (1958)
Galgóczy, G., Mandi, A., Jancsó, T.: Comparative examination of some broncholytic substances in chronic obstructive bronchitis. Pneumonologie148, 89–97 (1973)
Gayrard, P., Orehek, J., Charpin, J.: Effects bronchodilatateurs d'un atropinique de synthèse: Sch 1000, aerosol-doseur. Rev. franç. Mal. Resp.1, 481–492 (1973)
Goodman, L.S., Gilman, A.: The pharmacological basis of therapeutics. New York: McMillan 1965
Grewal, P.S.: Behandlung der obstruktiven Bronchitis mit einem Tropasäureester (Sch 1000. Diss. Münster 1969
Iravani, J., Schüler, K.G.: In vitro Untersuchungen der Bronchomotorik der Ratte. Pneumonologie144, 253–265 (1971)
Iravani, J.: Wirkung einiger bronchodilatierender Substanzen auf die Flimmeraktivität unter besonderer Berücksichtigung von Berotec®. Suppl. Internat. J. clin. Pharmacol.4, 20–24 (1971)
Islam, M.S., Rasche, B., Vastag, E., Ulmer, W.T.: Empfindlichkeitssteigerung der Bronchialmuskulatur durch proteolytische Fermente im Sputum. Pneumonologie146, 232–240 (1971)
Islam, M.S., Vastag, E., Ulmer, W.T.: Sulfurdioxide induced bronchial hyperreactivity against acetylcholine. Int. Arch. Arbeitsmed.29, 221–232 (1972)
Islam, M.S., Ulmer, W.T.: Der Wirkungsmechanismus von Serotonin (5-Hydroxytryptamin) und Histamin bei der Atemwegsobstruktion. Respiration30, 360–377 (1973)
Islam, M.S., Rasche, B., Vastag, E., Ulmer, W.T.: Über den Wirkungsmechanismus von Histamin in den Atemwegen. Respiration29, 538–548 (1972)
Itkin, J.H., Anand, S.C.: The role of atropine as a mediator blocker of induced bronchial obstruction. J. Allergy45, 178–186 (1970)
Kaliner, M., Orange, R.P., LaRaia, P.J., Austen, K.F.: Cholinergic enhancement of the immunologic release of histamine and slow-reacting substance of anaphylaxis (SRS-A) from human lung tissue. J. All. clin. Immunol.49, 88–89 (1972)
Kersten, W.: Protektive Wirkung von Ipratropiumbromid (Sch 1000) bei akuten Bronchokonstriktionen durch Allergeninhalation. Respiration31, 412–417 (1974)
Kock, M.A. de, Nadel, J.A., Zwi, S.: New method for perfusing bronchial arteries: Histamine bronchoconstriction and apnea. J. appl. Physiol.21, 185–194 (1966)
MacDonald, A.G., Ingram, C.G., McNeill, R.S.: The effect of propranolol on airway resistance. Brit. J. Anaesth.39, 919–926 (1967)
McNeill, R.S.: Effect of a beta-adrenergic blocking agent, propranolol, on asthmatics. Lancet1964 II, 1101–1102
Nadel, J.A., Widdicombe, J.G.: Effect of changes in blood gas tensions and carotid sinus pressure on tracheal volume and total lung resistance to airflow. J. Physiol.163, 13–33, (1962)
Nadel, J.A., Salem, A., Tamplin, B., Tokiwa, Y.: Mechanism of bronchoconstriction during inhalation of sulfur dioxide. J. appl. Physiol.20, 164–167 (1965)
Nadel, J.A., Widdicombe, J.G.: Reflex effects of upper airway irritation on total lung resistance and blood pressure. J. appl. Physiol.17, 861–865 (1962)
Nadel, J.A., Comroe, J.H.: Acute effects of inhalation of cigarette smoke on airway conductance. J. appl. Physiol.16, 713–716 (1961)
Nadel, J.A.: Structure-function relationships in the airways: Bronchoconstriction mediated via vagus nerves or bronchial arteries; peripheral lung constriction mediated via pulmonary arteries. Med. Thorac.22, 231–242 (1965)
Olsen, C.R., Colebatch, H.J.H., Mebel, P.E., Nadel, J.A., Staub, N.C.: Motor control of pulmonary airways studied by nerve stimulation. J. appl. Physiol.20, 202–208 (1965)
Poppius, H., Salorinne, Y., Viljanen, A.A.: Inhalation of a new anticholinergic drug, Sch 1000, in asthma and chronic bronchitis. Bull. Physio-path. Resp.8, 643–652 (1972)
Preisig, R.: The pharmacological basis of bronchospasmolytic agents. Respiration26, 95–102 (1965)
Reichel, G.: Chronische Bronchitis. Therapie-woche15, 610–615 (1970)
Simonsson, B.G., Jakobs, F.M., Nadel, J.A.: Role of autonomic nervous system and the cough reflex in the increased responsiveness of airway in patients with obstructive airway disease. J. clin. Invest.46, 1812–1818 (1967)
Sterling, G.M.: The mechanism of bronchoconstriction due to hypocapnia in man. Clin. Sci.34, 277–285 (1969)
Sterling, G.M.: The mechanism of bronchoconstriction due to hypoxia in man. Clin. Sci.35, 105–114 (1968)
Sterling, G.M., Batten, J.C.: Effect of aerosol propellants and surfactants on airway resistance. Thorax24, 228–231 (1969)
Thurlbeck, W.M., Henderson, J.A., Fraser, R.G., Bates, D.V.: Chronic obstructive lung disease. A comparison between clinical, roentgenologic, functional and morphologic criteria in chronic bronchitis, emphysema, asthma and bronchiectasis. Medicine (Baltimore)49, 81–145 (1970)
Ulmer, W.T., Dorsch, J., Iravani, J., Schüler, K.G., Stempel, G., Vastag, E.: Anticholinergika als Bronchodilatatoren. Arzneimittel-Forsch. (Drug Res.)23, 468–471 (1973)
Ulmer, W.T.: Inhalationstherapie mit Atropinderivaten. Med. Klin.66, 326–329 (1971)
Widdicombe, J.G.: Action potentials in parasympathetic and sympathetic efferent fibres to the trachea and lungs of dogs and cats. J. Physiol.186, 56–88 (1966)
Widdicombe, J.G., Kent, D.C., Nadel, J.A.: Mechanism of bronchoconstriction during inhalation of dust. J. appl. Physiol.17, 613–616 (1962)
Widdicombe, J.G., Sterling, G.M.: The autonomic nervous system and breathing. Arch. intern. Med.126, 311–329 (1970)
Widdicombe, J.G., Nadel, J.A.: Reflex effects of lung inflation on tracheal volume. J. appl. Physiol.18, 681–686 (1963)
Yu, D.Y.C., Galant, S.P., Gold, W.M.: Inhibition of antigen-induced bronchoconstriction by atropine in asthmatic patients. J. appl. Physiol.32, 823–828 (1972)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Vastag, E., Nagy, L. & Miskovits, G. Therapeutic value of anticholinergic agents in chronic obstructive pulmonary diseases. Eur J Clin Pharmacol 10, 201–208 (1976). https://doi.org/10.1007/BF00558330
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00558330